You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海吉亞醫療(06078.HK)擬2.54億元收購單縣海吉亞醫院17.62%股權
格隆匯 06-24 23:10

格隆匯6月24日丨海吉亞醫療(06078.HK)宣佈,於2021年6月24日,公司附屬公司海吉亞醫院管理作為買方與賣方(菏澤醫療、吉祥康達及海悦康健,該等公司為實施目標醫院的受限制股份計劃的平台而成立)訂立股權轉讓協議,據此,買方同意向賣方收購目標醫院合共約17.62%股權,現金代價合共為人民幣2.54億元。

據悉,目標醫院單縣海吉亞醫院有限公司成立於2012年11月,於2016年5月開始營運。目標醫院目前為一家位於中國山東省菏澤市的民營營利性二級綜合醫院。目標醫院目前持有有效的醫療機構執業許可證、放射診療許可證及輻射安全許可證,並提供廣泛的專科醫療服務,包括但不限於腫瘤科、骨科、心內科、ICU(重症監護室)、眼科及血液透析科。截至2020年12月31日,其擁有註冊牀位400張。

於完成後,公司將通過海吉亞醫療科技及伽瑪星科技間接持有目標醫院70%股權,並根據現有合約安排及新合約安排控制將由買方所持有的目標醫院29.18%股權,而賣方將持有目標醫院餘下0.82%股權。因此,目標醫院將繼續為公司的非全資附屬公司,且目標醫院的財務業績將繼續綜合入賬至集團財務報表。

此外,買方、伽瑪星科技、目標醫院及向上投資將按與現有合約安排大致相同的條款及條件就完成後由買方將持有的目標醫院約17.62%股權訂立新合約安排,這將使公司能夠控制目標醫院17.62%的股權並取得由此產生的經濟利益。

公吿稱,根據股權轉讓協議進行的收購事項將使集團於目標醫院的權益增加至99.18%,從而增強對目標醫院管理及運營的控制及影響力、增加其在目標醫院的經濟利益佔比,併為集團的戰略決策提供更多靈活性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account